Modulatory role of melatonin on superoxide release by spleen macrophages isolated from alloxan-induced diabetic rats

Bratislava Medical Journal

Volumn 110, Issue 9, 2009, Pages 517-522

  França, Eduardo Luzia ^a   Feliciano, Nagilla Daliane ^c   Silva, Karina Aparecida ^b   Bucalen Ferrari, Carlos Kusano ^a   Honorio França, Adenilda Cristina ^a  

^a FEDERAL UNIVERSITY OF MATO GROSSO   (Brazil)

^b Institute of Health Sciences   (Brazil)

^c FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

Author keywords

Antioxidant; Insulin; Macrophage; Melatonin; Pro oxidant; Superoxide

Indexed keywords

INSULIN; MELATONIN; SUPEROXIDE; SUPEROXIDE DISMUTASE;

ANIMAL; ARTICLE; CYTOLOGY; EXPERIMENTAL DIABETES MELLITUS; IN VITRO STUDY; MACROPHAGE; MALE; METABOLISM; RAT; SPLEEN; WISTAR RAT;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; INSULIN; MACROPHAGES; MALE; MELATONIN; RATS; RATS, WISTAR; SPLEEN; SUPEROXIDE DISMUTASE; SUPEROXIDES;

EID: 71949090011     PISSN: 00069248     EISSN: 13360345     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Klepac N, Rudes Z, Klepac R. Effects of melatonin on plasma oxidative stress in rats with streptozotocin induced diabetes. Biomed Pharmacother 2005; 60: 32-35.
2. Sudnikovich EJ, Maksimchik YZ, Zabrodskaya SV et al. Melatonin attenuates metabolic discorders due to streptoxotocin-induced diabetes rats. Eur J Pharmacol 2007; 569: 180-187.
3. Maestroni GJ. The immunotherapeutic potential of melatonin. Expert opin Invest Drugs 2001; 10: 467-476.
4. Srinivasan V, Maestroni GJ, Cardinally DP et al. Melatonin, immune function and aging. Immun Ageing 2005; 2: 17.
5. Pandi-Perumal SR, Trakht I, Srinivasan V et al. Physiological effects ofmelatonin: Role ofmelatonin receptors and signal transduction pathways. Prog Neurobiol 2008; 85: 335-353.
6. Maestroni GJ, Sulli A, Pizzorni C, Villaggio B, Cutolo M. Melatonin in rheumatoid arthritis: synovial macrophages show melatonin receptors. Ann NY Acad Sci 2002; 966: 271-275.
7. Garcia-Maurino S, Pozo D, Calvo JR, Guerrero JM. Correlation between nuclear melatonin receptor expression and enhanced cytokine production in human lymphocytic and monocytic cells lines. J Pineal Res 2000; 29: 129-137.
8. Pawlak J, Singh J, Lea RW, Skwarlo-Sonta K. Effect ofmelatonin on phagocytic activity and intracellular free calcium concentration intesticular macrophages from normal and streptozotocin-induced diabe.
9. Larijani B, Shooshtarizadeh P, Mosaffa N, Heshmat R. Polymor-phonuclear leucocyte respiratory burst activity correlates with serum zinc level in type 2 diabetic patients with foot ulcers. Br J Biomed Sci 2007; 64: 13-17.
10. Nielson CP, Hindson DA. Inhibition of polymorphonuclear leukocytes respiratory burst by elevated glucose concentrations in vitro. Diabetes 1989; 38: 1031-1035.
11. Jakelic J, Kokic S, Hozo I, Maras J, Fabijanic D. Nonspecificimmunity in diabetes: hyperglycemia decreases phagocytic activity ofleukocytes in diabetic patients. Med Arh 1995; 49: 9-12.
12. Fortes ZB, Farsky SP, Oliveira MA, Garcia-Leme J. Direct vital microspcopic stydy. Br J Pharmacol 1991; 40: 1267-1273.
13. Panneerselvam S, Govindasamy S. Sodium molybdate improves the phagocytic function in alloxan-induced diabetic rats. Chem Biol In teract 2003; 145: 159-163.
14. Alba-Loureiro TC, Hirabara SM, Mendonca JR, Curi R, Pithon-Curi TC. Diabetes causes market changes in fuction and metabolism of rat neutrophils. J Endocrinol 2006; 188: 295-303.
15. Aksoy N, Vural H, Sabuncu T. Effects of melatonin on oxidative-antioxidantive status of tissues in streptozotocin-induced diabetic rats. Cell Biochem Funct 2003; 21: 121-125.
16. Montilla PL, Vargas JF, Tunez IF. Oxidative stress in diabetic rats induced by streptozotocin: protective effects of melatonin. J Pineal Res 1998; 25: 94-100.
17. Ergiider IB, Karagen N, Karaca L. Reduced antioxidant potential & sensitivity to oxidation in plasma low density lipoprotein fraction in type 2 diabetes mellitus patients. Indian J Med Res 2006; 124: 207-210.
18. Peschke E. Melatonin, endocrine pancreas and diabetes. J Pineal Res 2008; 44: 26-40.
19. Robeva R, kirilov G, Tomava A, Kumanov PH. Melatonin-insulin interactions in patients with metabolic syndrome. J Pineal Res 2008; 44: 52-56.
20. Hoyos M, Guerrero JM, Perez-Cano R. Serum cholesterol and lipid peroxidation are decreased by melatonin in diet-induced hypercho-lesterolemic rats. J Pineal Res 2000; 28: 150-155.
21. Nishida S, Sato R, Murai I. Effect of pinealectomy on plasma levels of insulin and leptin ando n hepatic lipids in type 2 diabetic rats. J Pineal Res 2003; 35: 251-256.
22. Kadhim HM, Ismail SH, Hussein KI. Effects of melatonin and zinc on lipid profile and renal function in type 2 diabetic patients poorly corralled with metformin. J Pineal Res 2006; 41: 189-193.
23. Honorio-França AC, Carvalho MPSM, Isaac L, Trabulsi LR, Carneiro-Sampaio MM. Colostral mononuclear phagocytes are able to kill Enteropathogenic Escherichia coli (EPEC) opsonized by colostral IgA. Scand J Immunol 1997; 46: 59-66.
24. Novelli EL, Rodríguez NL, Franca EL, Gebra LMN, Ribas BO. High Dietary Carbohydrate and Panceatic lesion. Braz J Med Biol Res 1993; 26: 31-36.
25. Ledig M M, Paria JR, Mandel P. Superoxide dismutase activity in rat brain during acute and chronic alcohol intoxication. Neurochem Res 1981; 6: 385-390.
26. Endo H, Nito C, Kamada H, Yu F, Chan PH. Reduction in oxidative stress by superoxide dismutase over expression attenuates acute brain injury after subarachnoid hemorrhage via activation of Akt/glycogen synthase kinase-3beta survival signaling. J Cereb Blood Flow Metab 2007; 27: 975-982.
27. Pick E, Mizel D. Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using automatic enzyme immunoassay reader. J Immunol 1981; 130: 1910-1917.
28. Zar JH. Bioestatical Analysis. Englewood cliffs, Prentice-Hall In ternational Editions, 1984.
29. Ace Position statement on the insulin syndrome. Endocr Pract 2003; 9: 240-252.
30. Dunn JS, Sheenhan HL, McLetchie NGB. Necrosis of islets of Langerhans produced experimentally. Lancet 1943; 1: 484-487.
31. Watkins D, Cooperstein SJ, Lazarow A. Effect of alloxan on permeability of pancreatic islet tissue in vitro. Am J Physiol 1964; 207: 436-440.
32. Mordes JP, Rossini AA. Animal models of diabetes mellitus. Am J Med 1981; 70: 353-360.
33. Maritim AC, Sanders RA, Watkins B. Diabetes, Oxidative Stress, and Antioxidants: A Review. J Biochem Mol Toxicol 2003; 17: 24-38.
34. Ferrari CKB, Franca EL, Honorio-Franca AC, Souto PC. Antioxidants under the scrutiny of science. BMJ 2008; 336: 594.
35. Jiang ZY, Woollard AC, Wolff SP. Hydrogen peroxide production during experimental protein glycation. FEBS Lett 1990; 268: 69-71.
36. Tsai EC, Hirsch IB, Brunzell JD, Chait A. Reduced plasma pero-xyl radical trapping capacity and increases susceptibility of LDL to oxi dation in poorly controlled IDDM. Diabetes 1994; 43: 1010-1014.
37. Kawamura M, Heinecke JW, Chait A. Pathophysiological concentration of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway. J Clin Invest 1994; 94: 771-778.
38. Saxena AK, Srivastava P, Kale RK, Baquer NZ. Impaired antioxidants status in diabetic rat liver. Effect of vanadate. Biochem Pharmacol 1993; 45: 539-542.
39. Mekinova D, Chorvathova V, Volkovova K et al. Effect of intake of exogenous vitamins C, E and β-carotene on the antioxidative status in Kidneys of rats with streptozotocin-induced diabetes. Nahrung 1995; 39: 257-261.
40. Aragno M, Tamagno E, Gatto V et al. Dehydroepiandrosterone protects tissues of streptozotocin-treated rats against oxidative stress. Free Radic Biol Med 1999; 26: 1467-1474.
41. Kedziora-Kornatowska KZ, Luciak M, Paszkowski J. Lipid peroxidation and activities of antioxidant enzymes in the diabetic kidney: effect of treatment with angiotensin convertase inhibitors. IUBMB Life 2000; 49: 303-307.
42. Sanders RA, Rauscher FM, Watkins JB. Effects of quercetin on antioxidant defense in streptozotocin-induced diabetic rats. J Biochem Mol Toxicol 2001; 15: 143-149.
43. Besedovsky HO, del Rey A. Immune-neuro-endocrine interactions: Facts and hypotheses. Endocr Rev 1996; 17: 64-102.
44. Cutolo M, Villaggio B, Candido F, Valenti S, Giusti M, Felli L et al. Melatonin influences interleukin-12 and nitric oxide production by primary cultures of rheumatoid synovial macrophages and THP-1 cells. Ann New York Acad Sci 1999; 876: 246-254.
45. Skwarlo-Sonta K. Bi-directional communication between pineal gland and immune system. J Physiol 2002; 543: 6S-7S.
46. Brömme HJ, Mörke W, Peschke E, Ebelt H, Peschke D. Scavenging effect of melatonin on hydroxyl radicals generated by alloxan. J Pineal Res 2002; 29: 201-208.
47. Devi MMS, Suresh Y, Das UN. Preservation of the antioxidant status in chemically-induced diabetes mellitus by melatonin. J Pineal Res 2008; 29: 108-115.
48. Reiter RJ. Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J 1995; 9: 526-533.
49. Rodriguez C, Mayo JC, Sainz RM, Antolin I, Herrera F, Martin V et al. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004; 36: 1-9.
50. Honorio-França AC, Launay P, Carneiro-Sampaio MMS, Monteiro RC. Colostral neutrophils express IgA Fc receptors (CD89) lacking y chain association that mediate non-inflammatory properties of secretory IgA. J Leuk Biol 2001; 69: 289-296.
51. França-Botelho AC, Honório-França AC, França EL, Gomes MA, Costa-Cruz JM. Phagocytosis of Giardia lamblia trophozoites by human colostral leucocytes. Acta Paediat 2006; 95: 438-443.